Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sheng Hu HE"'
Autor:
Yi-Ming Li, Tian-Yuan Xiong, Kai Xu, Zhen-Fei Fang, Lei Jiang, Jun Jin, Sheng-Hu He, Yi-Ning Yang, Jing-Jing He, Yu-Heng Jia, Yi Zhang, Yong Peng, Yuan Feng, Mao Chen, Ning-Ning Wang
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 22, Pp 2678-2684 (2021)
Abstract. Background:. The past decade has witnessed an ever-increasing momentum of transcatheter aortic valve replacement (TAVR) and a subsequent paradigm shift in the contemporary management of severe aortic stenosis (AS). We conducted a multi-cent
Externí odkaz:
https://doaj.org/article/65fdb6cfd6334ca69be4d01b79749fbe
Autor:
Tian-Yuan Xiong, Yi-Ming Li, Yi-Jun Yao, Yu-Heng Jia, Kai Xu, Zhen-Fei Fang, Jun Jin, Guo-Sheng Fu, Yi-Ning Yang, Lei Jiang, Wei-Dong Li, Yan-Qing Wu, Yan-Song Guo, Ran Guo, Yun-Dai Chen, Yi Li, Yi-Bing Shao, Yi Zhang, Bo-Sen Yang, Yi-Ke Zhang, Jing-Jing He, Kai-Yu Jia, Sheng-Hu He, Fa-Xin Ren, Jian-Cheng Xiu, Xing-Hua Gu, Liang-Long Chen, Ke Han, Yuan Feng, Mao Chen, Ning-Ning Wang
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 22, Pp 2738-2740 (2021)
Externí odkaz:
https://doaj.org/article/bfa56c2b041a431eb5a512d1d28f6de7
Autor:
Jun-Bo Ge, Wei-Hu Fan, Jing-Min Zhou, Hai-Ming Shi, Fu-Sui Ji, Yang Wu, Yu-Lan Zhao, Jun Qian, Yuan-Zhe Jin, Ying-Wu Liu, Sheng-Huang Wang, Sheng-Hu He, Ping Yang, Jie Wu, Feng Lu, Zi-Shan Hou, Yan-Jie Yin, Xiu-Yuan Hao
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 2, Pp 185-192 (2021)
Abstract. Background:. The Shexiang Baoxin Pill (MUSKARDIA) has been used for treating coronary artery disease (CAD) and angina for more than 30 years in China. Nevertheless, methodologically sound trials on the use of MUSKARDIA in CAD patients are s
Externí odkaz:
https://doaj.org/article/b43d2e8c51dd4f97a9451fcb1041cdab
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 47:860-869
Autor:
Jun-Bo Ge, Wei-Hu Fan, Jing-Min Zhou, Hai-Ming Shi, Fu-Sui Ji, Yang Wu, Yu-Lan Zhao, Jun Qian, Yuan-Zhe Jin, Ying-Wu Liu, Sheng-Huang Wang, Sheng-Hu He, Ping Yang, Jie Wu, Feng Lu, Zi-Shan Hou, Yan-Jie Yin, Xiu-Yuan Hao
Publikováno v:
Chinese Medical Journal
Chinese Medical Journal, Vol 134, Iss 2, Pp 185-192 (2021)
Chinese Medical Journal, Vol 134, Iss 2, Pp 185-192 (2021)
Background:. The Shexiang Baoxin Pill (MUSKARDIA) has been used for treating coronary artery disease (CAD) and angina for more than 30 years in China. Nevertheless, methodologically sound trials on the use of MUSKARDIA in CAD patients are scarce. The
Publikováno v:
The Journal of Veterinary Medical Science
High-producing dairy cows are easily affected by left displacement of the abomasum (LDA) within 4 weeks postpartum. Although LDA is highly associated with metabolic disturbances, the related information on comprehensive metabolic changes, with the ex
Publikováno v:
Journal of clinical pharmacy and therapeuticsREFERENCES. 47(7)
It is well known that high in-stent thrombotic risk due to the superimposition of a platelet-rich thrombus was considered as the main origin of major adverse cardiac events after stent implantation. The clinical management of antiplatelet therapy str
Publikováno v:
American Journal of Hypertension. 36:71-71
Background To investigate the relationship between short-term blood pressure variability (BPV) after primary percutaneous coronary intervention (PPCI) and adverse cardiovascular outcomes 1 year after operation in patients with acute ST segment elevat
Publikováno v:
Journal of Veterinary Medical Science; 2020, Vol. 82 Issue 2, p115-124, 10p
Autor:
Yongjun Li, Xiaolong Wang, Arthur D. Zimmerman, Yutao Liu, Gangjian Qin, Yingjie Wang, Neal L. Weintraub, Lan Zhang, Yao Liang Tang, Sheng Hu He, Il-man Kim, Lijuan Chen, Xue Zhang, Wei Guo
Induced pluripotent stem cells (iPS) exhibit enhanced survival and proliferation in ischemic tissues. However, the therapeutic application of iPS cells is limited by their tumorigenic potential. We hypothesized that iPS cells can transmit cytoprotect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc8dbf4067c3cbd60b9b07a41cb41fa2
https://europepmc.org/articles/PMC4469495/
https://europepmc.org/articles/PMC4469495/